After Hours
There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities. Yahoo Finance discussed the stock recently as it posted Apellis Appoints Leading Expert Dr. Philip Ferrone as Chief Medical Retina Advisor.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Stocks Info
As a NASDAQ listed company, APLS falls under the Healthcare sector while operating within the Biotechnology industry segment. The current market capitalization of Apellis Pharmaceuticals Inc is $7.05B. A total of 1.04 million shares were traded on the day, compared to an average of 1.58M shares.
In the most recent transaction, Dunlop A. Sinclair sold 18,681 shares of APLS for 57.18 per share on Mar 19 ’24. After the transaction, the Director now owns 173,998 company shares. In a previous transaction on Mar 18 ’24, DeLong Mark Jeffrey sold 9,913 shares at 56.90 per share. APLS shares that Chief Business & Strat Officer owns now total 54,693.
Among the insiders who sold shares, Chopas James George disposed of 184 shares on Mar 15 ’24 at a per-share price of $56.46. This resulted in the VP/Chief Accounting Officer holding 38,883 shares of APLS after the transaction. In another insider transaction, Nicholson Nur sold 11,220 shares at $57.56 per share on Mar 13 ’24. Company shares held by the Chief Technical Officer now total 56,287.
In spite of price targets being rarely accurate, it tends to exert some kind influence from time to time, and was often accepted by the market as having some value. In terms of 52-week highs and lows, APLS has a high of $94.75 and a low of $19.83.
As of this writing, APLS has an earnings estimate of -$0.54 per share for the current quarter. EPS was calculated based on a consensus of 11 estimates, with a high estimate of -$0.28 per share and a lower estimate of -$0.88. The company reported an EPS of -$1.17 in the last quarter, which was -37.60% lower than expectations of -$0.85.
Balance Sheet Annually/Quarterly
The balance sheet of a company shows what assets and liabilities a company has, as well as the amount, equity investors have invested. With the help of this information, a company’s financial ratios can be calculated to give investors an overview of the company’s prospects. APLS’s latest balance sheet shows that the firm has $700.55M in Cash & Short Term Investments as of fiscal 2021. There were $210.22M in debt and $131.85M in liabilities at the time. Its Book Value Per Share was $1.63, while its Total Shareholder’s Equity was $198.66M.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for APLS is Buy with a score of 4.56.
